Literature DB >> 31348348

Impact of Septated First Dorsal Compartments on Symptomatic de Quervain Disease.

Derek T Bernstein1, Mirtha A Gonzalez1, Russell G Hendrick1, Nancy J Petersen1, Jose M Nolla1, David T Netscher1.   

Abstract

BACKGROUND: The authors conducted this study to determine whether septation of the first dorsal compartment is more prevalent in de Quervain tenosynovitis, and whether this contributes to failure of corticosteroid injection therapy.
METHODS: A retrospective review of 79 consecutive patients (85 wrists) with symptomatic de Quervain tenosynovitis treated with surgical release was performed. The number of corticosteroid injections performed preoperatively and the presence of first dorsal compartment septation determined intraoperatively were recorded. Correlation between the number of steroid injections and the presence of septation was evaluated. In addition, 48 matched cadaver upper extremities (96 wrists) that had not previously undergone surgery for de Quervain disease were evaluated for the presence of first dorsal compartment septation. The prevalence of septation was compared between matched wrists and against the surgically treated clinical cohort.
RESULTS: In the clinical cohort, 61.2 percent of wrists contained a septated first dorsal compartment. There was no correlation between the presence of a septated first dorsal compartment and the number of steroid injections before surgical release. In the cadaver portion of the study, 72.9 percent of wrists contained septa. There was no significant difference in the prevalence of septated first dorsal compartments between groups.
CONCLUSIONS: In the present study, the majority of wrists contained a septated first dorsal compartment, with no difference in the prevalence of septa between surgically treated patients and a cadaver sample that had not undergone prior surgical release. Furthermore, there was no correlation between the presence of septa and the number of preoperative corticosteroid injections administered. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31348348     DOI: 10.1097/PRS.0000000000005827

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  1 in total

1.  Effectiveness and safety of moxibustion for De Quervain disease: A protocol for systematic review and meta-analysis.

Authors:  Min Liu; Meinian Liu; Wenlong Yang; Ou Mei; Hanting Xia; Hong Tu; Li Wang; Xuyong Deng; Fengyun Yang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.